June 13, 2008 The Pump Handle 0Comment

FDA has been in the spotlight this week, and often not in a good way.


Kate Sheppard at Gristmill considers the prospects for climate legislation now that the Lieberman-Warner Climate Security Act has died.

Jeremy Jacquot at Science Progress worries about global warming’s effects on the oceans, while Sheril Kirshenbaum at The Intersection is mad at House Republicans for mucking up the Coastal Zone Management Act reauthorization.

Lisa Stiffler at Dateline Earth wonders how high gas prices will have to climb to curb driving.

Amanda at Enviroblog alerts us to House legislation that would ban bisphenol A from food and drink containers, while Matt Madia at Reg Watch notes that FDA’s lead scientist has asked the agency’s science board to convene a subcommittee to study the effects of BPA.

Sarah Rubenstein at WSJ’s Health Blog reports on the growing ranks of the underinsured – people who have health insurance, but not enough of it.

Steve Rosenzweig at Global Health Policy weighs in on the debate over the effects of disease-specific funding (like big pots of money for HIV/AIDS) on developing countries’ health systems.

Dave Munger at Cognitive Daily explains why the yammering colleague or noisy photocopier in your office might be bad for your health.

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.